GALT Chart
- 52-Week Range: $1.26 - $4.15
- Market Capitalization: $76.02M
- Short Percentage: 0%
- Target Price: $11.00
- Shares Outstanding: 59.36M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
GALT released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Galectin Therapeutics Reports 2021 Financial Results and Provides Business UpdateGlobeNewsWire | March 31st
- Galectin Therapeutics to Present at the H.C. Wainwright BioConnect ConferenceGlobeNewsWire | January 6th
- Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard E. UihleinGlobeNewsWire | December 21st
- Galectin Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire | October 5th
- Galectin Therapeutics, Inc. to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire | September 9th
Company Info
Website: https://galectintherapeutics.com
Address: 4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071
Sector: Healthcare
Industry: Biotechnology
Full time employees: 9
Address: 4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071
Sector: Healthcare
Industry: Biotechnology
Full time employees: 9
$GALT buy more doomers!!!
$GALT who here can't stand the CEO?
$GALT push baby push!
$GALT See ya Monday
$GALT I bought the dip